×

Spark Therapeutics jumps after favorable FDA panel vote

5:14 PM ET Thu, 12 Oct 2017

CNBC's Meg Tirrell reports on Spark Therapeutics shares jumping after the FDA panel votes in favor of the company's gene therapy.